Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 122

1.

Cross-validation of Peak Oxygen Consumption Prediction Models From OMNI Perceived Exertion.

Mays RJ, Goss FL, Nagle EF, Gallagher M Jr, Haile L, Schafer MA, Kim KH, Robertson RJ.

Int J Sports Med. 2016 Jul 13. [Epub ahead of print]

PMID:
27410768
2.

Adult adherent cell therapy for ischemic stroke: clinical results and development experience using MultiStem.

Mays R, Deans R.

Transfusion. 2016 Apr;56(4):6S-8S. doi: 10.1111/trf.13562. No abstract available.

PMID:
27079323
3.

Multipotent adult progenitor cells for hypoxic-ischemic injury in the preterm brain.

Jellema RK, Ophelders DR, Zwanenburg A, Nikiforou M, Delhaas T, Andriessen P, Mays RW, Deans R, Germeraad WT, Wolfs TG, Kramer BW.

J Neuroinflammation. 2015 Dec 23;12:241. doi: 10.1186/s12974-015-0459-5.

4.

Intravenous multipotent adult progenitor cell treatment decreases inflammation leading to functional recovery following spinal cord injury.

DePaul MA, Palmer M, Lang BT, Cutrone R, Tran AP, Madalena KM, Bogaerts A, Hamilton JA, Deans RJ, Mays RW, Busch SA, Silver J.

Sci Rep. 2015 Nov 19;5:16795. doi: 10.1038/srep16795.

5.

Modification of Silicone Elastomer Surfaces with Zwitterionic Polymers: Short-Term Fouling Resistance and Triggered Biofouling Release.

Shivapooja P, Yu Q, Orihuela B, Mays R, Rittschof D, Genzer J, López GP.

ACS Appl Mater Interfaces. 2015 Nov 25;7(46):25586-91. doi: 10.1021/acsami.5b09199. Epub 2015 Nov 16.

PMID:
26554418
6.

Methodological Quality of Motor Intervention Randomized Controlled Trials in Stroke Rehabilitation.

McIntyre A, Campbell N, Vermeer J, Mays R, Janzen S, Teasell R.

J Stroke Cerebrovasc Dis. 2016 Feb;25(2):248-53. doi: 10.1016/j.jstrokecerebrovasdis.2015.09.024. Epub 2015 Oct 20.

PMID:
26500172
7.

Neuroinflammatory signals enhance the immunomodulatory and neuroprotective properties of multipotent adult progenitor cells.

Ravanidis S, Bogie JF, Donders R, Craeye D, Mays RW, Deans R, Gijbels K, Bronckaers A, Stinissen P, Pinxteren J, Hellings N.

Stem Cell Res Ther. 2015 Sep 16;6:176. doi: 10.1186/s13287-015-0169-z.

8.

Burden of dose escalation with tumour necrosis factor inhibitors in rheumatoid arthritis: a systematic review of frequency and costs.

Moots RJ, Mays R, Stephens J, Tarallo M.

Clin Exp Rheumatol. 2015 Sep-Oct;33(5):737-45. Epub 2015 Jun 8. Review.

PMID:
26053198
9.

Community-based walking exercise for peripheral artery disease: An exploratory pilot study.

Mays RJ, Hiatt WR, Casserly IP, Rogers RK, Main DS, Kohrt WM, Ho PM, Regensteiner JG.

Vasc Med. 2015 Aug;20(4):339-47. doi: 10.1177/1358863X15572725. Epub 2015 Mar 9.

10.
11.

Oral care post stroke: a scoping review.

Kwok C, McIntyre A, Janzen S, Mays R, Teasell R.

J Oral Rehabil. 2015 Jan;42(1):65-74. doi: 10.1111/joor.12229. Epub 2014 Sep 22. Review.

PMID:
25244419
12.

Therapy for peripheral artery disease: gaps in treating patients with claudication.

Mays RJ, Regensteiner JG.

Circulation. 2014 Sep 16;130(12):929-31. doi: 10.1161/CIRCULATIONAHA.114.011990. Epub 2014 Aug 5. No abstract available.

13.

Prediction of VO2 peak using OMNI Ratings of Perceived Exertion from a submaximal cycle exercise test.

Mays RJ, Goss FL, Nagle EF, Gallagher M, Schafer MA, Kim KH, Robertson RJ.

Percept Mot Skills. 2014 Jun;118(3):863-81. doi: 10.2466/27.29.PMS.118k28w7. Epub 2014 May 21.

14.

Stem cells as an emerging paradigm in stroke 3: enhancing the development of clinical trials.

Savitz SI, Cramer SC, Wechsler L; STEPS 3 Consortium.

Stroke. 2014 Feb;45(2):634-9. doi: 10.1161/STROKEAHA.113.003379. Epub 2013 Dec 24. Review. No abstract available.

15.

Intravenous multipotent adult progenitor cell therapy attenuates activated microglial/macrophage response and improves spatial learning after traumatic brain injury.

Bedi SS, Hetz R, Thomas C, Smith P, Olsen AB, Williams S, Xue H, Aroom K, Uray K, Hamilton J, Mays RW, Cox CS Jr.

Stem Cells Transl Med. 2013 Dec;2(12):953-60. doi: 10.5966/sctm.2013-0100. Epub 2013 Nov 4.

16.

A review of educational programs to reduce UTIs among individuals with SCI.

Mays R, McIntyre A, Mehta S, Hill D, Wolfe D, Teasell R.

Rehabil Nurs. 2014 Sep-Oct;39(5):240-9. doi: 10.1002/rnj.130. Epub 2013 Oct 29. Review.

PMID:
24170348
17.

Eruptive squamous cell carcinomas after vemurafenib therapy.

Mays R, Curry J, Kim K, Tsai K, Arora A, Khan F, Ramirez-Fort M, Ciurea A.

J Cutan Med Surg. 2013 Nov-Dec;17(6):419-22.

PMID:
24138980
18.

Community walking programs for treatment of peripheral artery disease.

Mays RJ, Rogers RK, Hiatt WR, Regensteiner JG.

J Vasc Surg. 2013 Dec;58(6):1678-87. doi: 10.1016/j.jvs.2013.08.034. Epub 2013 Oct 5. Review.

19.

Examining the effectiveness of intrathecal baclofen on spasticity in individuals with chronic spinal cord injury: a systematic review.

McIntyre A, Mays R, Mehta S, Janzen S, Townson A, Hsieh J, Wolfe D, Teasell R.

J Spinal Cord Med. 2014 Jan;37(1):11-8. doi: 10.1179/2045772313Y.0000000102. Epub 2013 Nov 26. Review.

20.

Microfluidic channels fabricated from poly(vinylmethylsiloxane) networks that resist swelling by organic solvents.

Mays RL, Dickey MD, Genzer J.

Lab Chip. 2013 Nov 21;13(22):4317-20. doi: 10.1039/c3lc50848j.

PMID:
24089248
Items per page

Supplemental Content

Loading ...
Write to the Help Desk